For the Quarter Ending September 2024
North America
In the third quarter of 2024, the North American market for Amoxicillin Trihydrate exhibited a dynamic pricing landscape, influenced by a variety of factors that affected different sectors. The USA, in particular, experienced significant price fluctuations, resulting in an unpredictable pricing environment throughout the quarter.
At the beginning of the quarter, prices saw a decline, driven by several factors that collectively exerted downward pressure on the market. A key influence was the inflation rate, which had previously surged above 9% but began to stabilize significantly. This cooling inflation led to reduced overhead costs for businesses, allowing them to lower Amoxicillin Trihydrate prices for consumers. However, as the quarter advanced, the pricing trend reversed, and prices began to rise due to a mix of economic and logistical factors. Consumer confidence reached a six-month high, fueled by an improved outlook on the economy and inflation, despite ongoing concerns about the labor market. This renewed optimism translated into increased demand for Amoxicillin Trihydrate, which in turn applied upward pressure on prices. In anticipation of this rising demand and potential supply chain challenges, market participants actively began to build their inventories.
Overall, the pricing trajectory for Amoxicillin Trihydrate in North America during Q3 2024 was characterized by an initial decline, followed by a subsequent increase, reflecting the intricate interplay of economic conditions, market sentiment, and logistical dynamics.
Asia Pacific
In Q3 2024, the Amoxicillin Trihydrate market in the APAC region displayed a varied pricing trend, shaped by multiple influencing factors. Initially, prices declined in July, primarily due to sluggish consumption levels both domestically and internationally. The Chinese market experienced a downturn at the start of the quarter, which was exacerbated by limited support from downstream sectors. Moreover, rising freight costs, driven by disruptions in global maritime traffic, significantly hindered international demand for Amoxicillin Trihydrate. As the quarter progressed, however, a shift occurred, and prices began to climb. This upward movement was supported by robust demand from end-user industries and effective inventory management strategies employed by market participants. The global economic recovery efforts also played a pivotal role in this price increase. As industries adapted to the challenges posed by the ongoing Red Sea conflict, international demand saw a resurgence, further bolstering prices. In China, the market exhibited notable price fluctuations, reflecting the delicate balance between supply and demand. The interplay of these various factors underscored the complexities of the Amoxicillin Trihydrate market in the APAC region during this quarter.
Europe
During the third quarter of 2024, the Amoxicillin Trihydrate pricing landscape in Europe displayed a mixed trend, shaped by several influential factors. At the start of the quarter, prices experienced a decline, primarily driven by weaker-than-expected demand in the German market, particularly in the nutraceutical and pharmaceutical sectors. This lack of demand prompted market participants to adopt a cautious approach, resulting in significant inventory maintenance to meet current consumption needs in Germany. However, as the quarter progressed, prices began to rise. This change was propelled by a combination of robust demand from end-user industries, strategic inventory management by companies bracing for potential disruptions, and favorable macroeconomic conditions. The ongoing conflict in the Red Sea added complexity to the situation by disrupting global maritime traffic, leading to logistical challenges and constraining the supply of Amoxicillin Trihydrate. These supply limitations contributed to upward pressure on prices as market dynamics evolved. Additionally, improvements in consumer sentiment, particularly in Germany, played a vital role in revitalizing demand and fostering a more optimistic outlook for the market. Despite facing a range of challenges, companies actively sought to enhance their stockpiles in anticipation of shipping delays, further reinforcing the upward trend in prices.
For the Quarter Ending June 2024
North America
In the second quarter of 2024, the pricing environment for Amoxicillin Trihydrate in North America experienced a generally negative trend, marked by a steady upward trend witnessed in first two months.
Starting with the month of April and until May, the market demand remained on the upper side with traders actively focused on procuring the materials. Moreover, the early onset of the peak season further boosted demand, as companies stockpiled to mitigate potential supply disruptions during critical periods, such as the autumn months. Additionally, the scramble for available space in anticipation of prolonged lead times added to the demand pressure. Furthermore, the looming specter of potential disruptions from the war in Gaza prompted companies to increase their inventory levels as a precautionary measure, further drove the persistent rise in procurement activity.
However, the market witnessed an opposing trajectory as June commenced, several significant factors influenced the market prices, including subdued business sentiments and reduced demand from end-user pharmaceutical and healthcare sectors. The downturn in economic confidence, coupled with the Federal Reserve's stringent interest rate policies, exerted financial pressure on consumers, thereby curbing their purchasing capacity. In the USA, which saw the most pronounced price changes, the market was notably influenced by these compounded pressures. The overall trend was characterized by a steady decrease, reflecting the broader sentiment of cautious consumer spending and heightened economic uncertainty. Seasonal factors, such as the reduction of bacterial illnesses with the arrival of warmer weather, also played a role in lowering demand for Amoxicillin Trihydrate. Comparing the first and second halves of the quarter, prices declined by an additional 2%, indicative of the persistent downward pressure. Conclusively, the quarter-ending price for Amoxicillin Trihydrate (USP, FDA) CFR Houston in the USA settled at USD 34815/MT, underscoring the negative pricing environment that characterized the quarter.
APAC
In Q2 2024, the pricing landscape for Amoxicillin Trihydrate in the APAC region has experienced a pronounced downward trajectory with a modest rise witnessed until the middle of the quarter. Initially the quarter witnessed an optimistic trajectory driven by growing market confidence, led to heightened consumer demand as consumers sought to purchase the medication before prices potentially rose further. Additionally, the devaluation of the Chinese yuan against the USD made exports more appealing to international buyers, thus increasing demand in overseas markets. Furthermore, the easing of tensions in the Middle East during the latter part of the month likely played a role in the surge in shipments and demand, as it created a more stable trading environment. Lastly, with the beginning of the second quarter the downstream merchants and traders gradually witnessed higher regional and overseas quotations supporting the overall trajectory until may. Contrary to this, the market witnessed an upside-down trajectory as June commenced. A notable contributor to this decline has been diminished demand from end-user sectors, coupled with accumulating inventories held by market participants. Reduced inquiries from international markets further exacerbated the oversupply, leading to a negative pricing environment. Moreover, the absence of substantial disruptions or plant shutdowns indicated a relatively stable production landscape, further intensifying the imbalance between supply and demand. Focusing on China, the market experienced the most significant price fluctuations within the APAC region. Overall trends indicated a downward movement in prices, influenced by seasonality factors and a reduced incidence of bacterial illnesses typically treated with Amoxicillin Trihydrate. Despite an initial uptick in economic activity post-holidays, insufficient domestic demand and a lack of inquiries from overseas compounded price pressures. The comparative analysis revealed a 1% price decrease from the previous quarter in 2024, with a more notable reduction of 3% observed in the last month of the quarter. Concluding Q2 2024, the price of Amoxicillin Trihydrate in China settled at USD 32,650/MT.
Europe
Following the market trajectory of other importing nations, including the USA, the second quarter of 2024 saw a consistent decline in Amoxicillin Trihydrate prices in the Europe region, driven by multiple market forces. A key factor behind the reduction in prices was sluggish demand from end-user sectors, including pharmaceuticals and healthcare, which failed to recover as anticipated, leading to an oversupply situation. Additionally, Significant logistical challenges, including port congestions and geopolitical disruptions, exacerbated the supply chain issues, contributing to a bearish market sentiment, ahead of persistent rise in freight cost, resulting in a higher product import cost. Focusing on Germany, which experienced the most pronounced price changes, the overall trend reflected a steady decrease in Amoxicillin Trihydrate prices. The correlation between seasonality and price changes was evident, as warmer weather reduced demand for antibiotics. The market sentiment remains negative, influenced by dampened consumer confidence and high inventory levels built in anticipation of a demand spike that did not materialize. Overall, the quarter concluded with a price of USD 34250/MT of Amoxicillin Trihydrate, reflecting the overarching negative pricing environment.
For the Quarter Ending March 2024
North America
In Q1 2024, the pricing of Amoxicillin Trihydrate in the North America region displayed a mixed trend, influenced by a variety of factors. Initially, prices saw a modest decrease as weakened demand from downstream industries and ample supply in the market contributed to a decline. This decrease in demand was exacerbated by inflationary pressures and the Federal Reserve's decision to maintain steady rates.
However, prices surged in the middle of the quarter due to increased demand from downstream industries, intensifying the already tight supply conditions in the domestic market. The imminent arrival of the spring festival in China further fueled demand, prompting market retailers and distributors to proactively replenish their inventories. Additionally, disruptions in key maritime routes, such as the Red Sea and Panama Canal, presented challenges for shippers importing Amoxicillin Trihydrate into the US, exacerbating supply constraints. Nevertheless, prices experienced a moderate decline again in March due to a downturn in business sentiments, casting uncertainty over the economy. This lack of confidence translated into subdued demand from end-user pharmaceutical and healthcare industries, leading to a downward trajectory in Amoxicillin Trihydrate prices.
The quarter-ending price for Amoxicillin Trihydrate (USP, FDA) CFR Houston in the USA was recorded at USD 35145/MT. In conclusion, the pricing of Amoxicillin Trihydrate in the North America region during Q1 2024 has been influenced by a combination of demand patterns, consumer sentiment, and inventory management strategies.
Asia Pacific
In Q1 2024, the pricing dynamics of Amoxicillin Trihydrate in the APAC region were shaped by several factors. Initially, prices experienced a slight decline as reduced demand from downstream sectors negatively impacted the market. The manufacturing environment in China encountered challenges, marked by a slow domestic recovery and subdued external demand. Midway through the quarter, prices surged primarily due to constrained availability caused by the Spring Festival. The festival led to factory shutdowns and reduced production, resulting in insufficient supply even after the holidays as production took time to normalize. The seasonal transition from winter to spring further increased demand, exacerbating the supply-demand gap. Heightened inquiries from other major markets and concerns about the stability of existing supplies also contributed to sustained price elevation. However, prices declined again in March despite an uptick in economic activity in China following an extended holiday period. This positive momentum was overshadowed by concerns about inadequate domestic demand. In conclusion, the quarter-ending price for Amoxicillin Trihydrate in China stood at USD 32800 per metric ton (USP, FDA) FOB Shanghai.
Europe
In Q1 2024, the pricing dynamics of Amoxicillin Trihydrate in the Europe region were influenced by several factors. Initially, prices experienced a notable decline, reflecting subdued consumer sentiments and concerns about the economy. This decrease in demand from both the pharmaceutical and healthcare sectors contributed to the decline in prices for Amoxicillin Trihydrate. However, prices surged in the middle of the quarter due to various factors, including rising consumer demand, logistical challenges, and limited inventories within the domestic market. Disruptions in shipping and logistics, typical during the Spring festival in China, led to delays and increased transportation expenses. These additional costs were passed on to buyers, contributing to the upward trend of Amoxicillin Trihydrate prices. Furthermore, disruptions in shipping and logistics caused by attacks on cargo ships in the Red Sea also significantly impacted pricing. Major shipping companies were forced to redirect their routes, resulting in increased shipping costs and prolonged delivery times. These disruptions contributed to supply chain challenges and limited availability of Amoxicillin Trihydrate. Nevertheless, prices experienced a significant decline again in March as the market grappled with persistently poor performance in new industrial orders. This was characterized by inadequate domestic demand juxtaposed against a relatively high backlog, contributing to the downward trajectory of prices for Amoxicillin Trihydrate in the Europe region. Ultimately, the final price for Amoxicillin Trihydrate (USP, FDA) CFR Hamburg in Germany for the quarter was recorded at USD 34800 per metric ton.
For the Quarter Ending December 2023
North America
The North American Amoxicillin Trihydrate market faced challenges in the fourth quarter of 2023. This period witnessed a range of factors that notably impacted market dynamics and pricing. These elements included trade fluctuations, seasonal variations, and increased interest rates. Although prices initially declined in the middle of the quarter, they experienced an upward trend towards the end.
Firstly, the market experienced a decline in demand from the pharmaceutical and healthcare industries, leading to excess supply and an overall decrease in prices. Additionally, the Federal Reserve's decision to maintain high-interest rates impacted consumer purchasing power, further contributing to the weakened demand for Amoxicillin Trihydrate. Furthermore, the slowdown in inflation and the decrease in energy prices affected business and shipping costs, adding to the downward price trend. Focusing on the United States, it experienced a bearish market situation with declining demand and limited availability of Amoxicillin Trihydrate. The high-interest rates and inflationary pressures affected consumer confidence and purchasing power, resulting in a subdued performance of the market. However, the onset of the cold and flu season during December heightened the prevalence of bacterial infections, resulting in an increased overall demand for Amoxicillin trihydrate in the domestic market, which surged the prices.
The price of Amoxicillin Trihydrate (USP, FDA) CFR Houston in the USA for the fourth quarter of 2023 was USD 35815/MT. This price represents the quarter-ending value and reflects the overall market conditions and factors mentioned above.
APAC
Amoxicillin Trihydrate pricing in the APAC region during the fourth quarter of 2023 was influenced by several key factors. Firstly, there was a decline in demand for Amoxicillin Trihydrate both domestically and internationally, primarily due to weak market conditions and decreased export sales. This was attributed to the ongoing economic uncertainties and the impact of higher interest rates on manufacturing sectors in major export markets such as Europe and the USA. Furthermore, the global decrease in crude oil prices contributed to lower transportation costs and production expenses, further affecting the pricing of Amoxicillin Trihydrate. In terms of China, the largest market for Amoxicillin Trihydrate in the APAC region, the prices experienced a downward trend during the quarter. The country's manufacturing sector contracted for the second consecutive month, indicating a weakening momentum in the economy. The decline in new export orders and the ongoing trade tensions impacted the demand for Amoxicillin Trihydrate from foreign markets. However, there were rise in prices in December amid positive signs in terms of domestic demand, with steady growth in new orders and overall manufacturing activity. In conclusion, Amoxicillin Trihydrate pricing in the APAC region during the fourth quarter of 2023 was influenced by factors such as weak demand, ample supply, and global economic uncertainties. The quarter saw minimal changes in prices, with a slight increase from the previous quarter. The latest price of Amoxicillin Trihydrate (USP, FDA) FOB Shanghai in China for the current quarter is USD 33800/MT.
Europe
The fourth quarter of 2023 proved to be a challenging period for Amoxicillin Trihydrate pricing in the European region. The market was influenced by several key factors. Firstly, there was a decline in demand from end-users, driven by reduced consumption and constrained consumer spending. This was due to the persistent inflationary pressures, particularly in Germany, where consumer confidence was significantly affected. In terms of Germany specifically, the country experienced a decrease in overall demand due to elevated interest rates implemented by the European Central Bank. The manufacturing sector observed a significant decline in new orders, further impacting market dynamics. Despite these challenges, the market saw an increase in Amoxicillin Trihydrate prices in December due to, propelled by improved consumer demand due to seasonal changes. The price of Amoxicillin Trihydrate in Germany for the fourth quarter of 2023 was USD 35460/MT. This represents a 4.83% increase compared to the same quarter last year. However, there was a 1.15% decrease in price compared to the previous quarter. Throughout the fourth quarter, the market conditions exhibited a mixed scenario, with fluctuations in demand and supply playing a significant role in influencing pricing trends.
For the Quarter Ending September 2023
North America
Prices for amoxicillin trihydrate fell by 4.24% in September 2023 compared to July levels. Growth in US business activity slowed in the third quarter due to lower domestic and international demand. In the United States, inflation rose to 3.7% in August for the first time since June 2022, as a sharp increase in energy prices pushed prices higher toward the end of the summer, weighing on consumer confidence even more. Inflationary pressures indicate that the US economy is drifting further away from the Federal Reserve's 2% target rate, prompting officials to consider raising interest rates later this year. The Federal Reserve raised its key policy interest rate in July by 0.25 percent, the eleventh time in 17 months, to confront persistent inflation in the US economy, resulting in decreasing market demand. In September, rising gasoline costs and high-interest rates further contributed to increased economic uncertainty and lowered consumer confidence. Manufacturers reported a further decline in new orders, with the rate of contraction being the fastest, contributing to the negative trend. Businesses have continued to liquidate their backlog and stock in order to maintain profitability.
Asia Pacific
Prices for Amoxicillin trihydrate in China fell by 4.29 percent in September 2023 as compared to July values. The Chinese economy faced new obstacles and challenges, slowing economic momentum. The official manufacturing PMI (Purchasing Managers' Index) stood at 49.3 in July, according to the National Bureau of Statistics (NBS). However, this figure stayed below 50, indicating shrinkage rather than expansion. Business and production activity have dropped because of lower international orders and sales. Inflation and increased interest rates in the United States, Europe, and major export markets continue to weigh on Chinese demand, with the new export order sub-index dropping for the sixth month in a row in August. In September, China's manufacturing purchasing managers' index (PMI) was 50.2, returning to the expansion zone. This data shows that market demand in the manufacturing sector has gradually improved, and company operations have risen at a quicker rate. However, sluggish foreign demand continued to weigh on the outlook even as output grew, which maintained the Amoxicillin trihydrate market on the weaker side.
Europe
Since the beginning of the third quarter, Amoxicillin Trihydrate prices in Germany have fallen by 4.30% in September. The purchasing managers' index (PMI) in Germany fell to 41 in July, indicating a consistent decline in new orders from both domestic and international markets despite adequate inventories among market participants. Furthermore, consumer confidence remained low in August as a result of consistent rate hikes, high inflation, the energy crisis, and geopolitical dynamics. The continued high inflation rate, fueled by high energy and oil prices, harmed consumer spending power and aided the decline in amoxicillin trihydrate prices. Germany's industrial sector, which accounts for around one-fifth of the country's economy, remained in a slump in September owing to sluggish demand and quickly declining output, which also led to a drop in amoxicillin trihydrate prices. The European Central Bank agreed to increase the interest rates for the tenth time in a row in September to combat stubborn inflation, which has further kept the market demand on the lower side and supported the downward trajectory.
For the Quarter Ending June 2023
North America
In the United States, the price of Amoxicillin Trihydrate was down 7.04 percent in June from levels seen in April. Prices have declined due to increased supply, lower domestic and overseas market demand, and higher API (Active Pharmaceutical Ingredients) prices. China is the main API exporter to the US. As COVID regulations were eased, exports of amoxicillin trihydrate to the US increased, which increased supply in the US market, putting downward pressure on prices. Additionally, inflation slowed down in the second quarter as a result of the Federal Reserve's rate hike, which subsequently led to lower demand for amoxicillin hydrate in the US market, driving prices down. In addition, the US dollar strengthened against the Chinese yuan in June 2023, making imports in the US cheaper, resulting in increased amoxicillin trihydrate availability, supporting the downtrend. Market traders and suppliers were forced to lower prices in order to clear their stockpiles amid weaker demand from end-consumers, which has maintained the adverse market situation.
Asia Pacific
In China, Amoxicillin trihydrate prices dropped 4.36% in June in comparison to the levels seen in April. Factors responsible for this downtrend include increased supply, decreased demand, and currency fluctuation. Economic momentum in China remained on the weaker side, indicating a slowing down of the global economy, which added pressure on external demand from end-user industries. According to the National Bureau of Statistics (NBS), China's manufacturing PMI (Purchasing Managers' Index) remained below 50 throughout the second quarter, indicating a contraction in the manufacturing sector. This slows down production due to weak demand from end-user healthcare and pharmaceutical sectors, with reduced purchasing activity and new orders, driving down the price of amoxicillin trihydrate. Additionally, the Chinese Yuan fell against the US Dollar in June, indicating a slowdown in China's post-pandemic recovery due to weaker consumer confidence. Meanwhile, Russia's invasion of Ukraine continued to create obstacles for exporters, affecting API supply chains, and leading to an increased supply of amoxicillin hydrate in the China market, causing prices to fall.
Europe
In Germany, a downward trend of 5.64% for Amoxicillin Trihydrate prices has been recorded in June since the beginning of the second quarter. Supporting factors for this downtrend include weak purchasing power and overflowing inventory in the market. Amoxicillin Trihydrate supply has increased due to lower APIs prices and increased exports of Amoxicillin Trihydrate from overseas countries such as China. In addition, the German government relaxed some generic drug import protocols that increased the availability of the generic version of amoxicillin trihydrate, causing the price of amoxicillin trihydrate to fall further. In addition, the Manufacturing PMI (Purchasing Managers Index) fell to 41 in June, from 43.2 in May and 44.5 in April, indicating a slowing down of the German economy. The German economy is impacted by increased inflation and higher interest rate imposed by the European Central Bank, resulting in higher food and energy prices. This has increased the cost of living, reducing the purchasing activity by consumers, further supporting the downward trend of Amoxicillin Trihydrate prices.
For the Quarter Ending March 2023
North America
In the first quarter of 2023, Amoxicillin Trihydrate showed depreciated market dynamics with minimal variation. Prices rose at the start of Q1 2023 and stayed up through the end of February thanks to merchant supplies to satisfy demand and ongoing purchases from the pharmaceutical end-user business. The settlement price of Amoxicillin Trihydrate API was reported at USD 38850/MT CFR Houston, with an average quarterly declination of 0.81%. Additionally, the market position was favorably impacted by improved trade flow and simpler logistic charges than the previous quarter. On the other hand, prices decreased in March due to sufficient stocks, low-end-user sector offtakes, and a decrease in freight costs.
Asia
Amoxicillin Trihydrate prices witnessed a positive trajectory in the APAC region in the first quarter of 2023. The prices decreased at the start of Q1 2023, with enough inventories and a low demand outlook. Also, feeble production activities kept the market situation weak. With the commencement of February, After the Lunar New Year break, the Chinese pharmaceutical markets technically returned on a positive note with an increase in orders and shipments from both the domestic and the international market. As the market was reopened, factory and port operations resumed. At the termination of Q1 2023, the settlement price of Amoxicillin Trihydrate API accessed at USD 37550/MT FOB Shanghai with an average quarterly inclination of 0.96%.
Europe
Amoxicillin Trihydrate displayed weak market dynamics with little volatility in the first quarter of 2023. Due to merchant supply to meet demand and continued purchases from the pharmaceutical end-user sector, prices increased at the beginning of Q1 2023 and remained up until the end of February. The ease with which trade might be suspended contributed to the market trend for Amoxicillin Trihydrate. Amoxicillin Trihydrate API's settlement price was reported to be USD 140650/MT CFR Hamburg, with a quarterly average declination of 1.84%. The market position also benefited from an increase in trade flow and simpler logistic costs compared to the prior quarter. On the other hand, prices dropped in March because of ample supplies, offtakes from the low-end user sector, and lower freight costs.
For the Quarter Ending December 2022
North America
In the North American region, the Amoxicillin Trihydrate price trend observed an escalating trajectory in the H2 of Q4 2022 owing to limited inventories among regional retailers. The Golden week vacation interrupting imports from China during the first week of October propelled a few domestic retailers to raise their price quotations in response to the enduring demand from the downstream sector. Moreover, the buying activities were elevated due to rising offtakes from end-user pharmaceutical and healthcare sectors. The tiebreakers, which included China’s Covid lockdowns, Russia conflicts in Ukraine, rising inflation in the US, and harsh weather conditions, continued to put fragile supply chains in danger throughout most of the quarter. By the termination of the quarter, a decrement was seen in the market dynamics of Amoxicillin Trihydrate due to weak demand and a dull purchasing mood ahead of the Christmas Holiday. Therefore, the CFR Houston prices for Amoxicillin Trihydrate in the United States shifted from USD 47270 /MT in October to USD 39855/MT in December.
Asia- Pacific
In the Asia Pacific, Amoxicillin Trihydrate witnessed mixed market sentiments during the last quarter of 2022. However, FOB Shanghai values changed from USD 41220/MT to USD 36505/MT from October to December. In the first half of Q4, the robust demand from several end-user pharmaceutical and healthcare industries has impacted the Amoxicillin Trihydrate prices in the Chinese market. The halt in production activities during the Golden week vacations in the first week of October resulted in low inventories among domestic retailers, which in turn supported the pricing tendency in the market. However, the prices started to decline from the H2 of Q4 as industries resumed production, and the domestic manufacturers and suppliers met the total demand during the quarter with an acceptable supply of inventories on hand.
Europe
In Europe, the Amoxicillin Trihydrate resembled the similar market dynamics of North America and the Asia Pacific region. However, the price of Amoxicillin Trihydrate saw an increase till November 2022, with CFR Hamburg values settled at USD 49950/MT in October and then rising even further to USD 50580/MT in November. Supply constraints and persistent demand from end-user sectors were the driving forces behind the price increase. Additionally, when import costs increased, domestic industries were obliged to change their product line-ups to increase profit margins. Later, in December, feeble purchasing activities were observed due to lowering demand from the regional market, resulting in a price decline. Local traders reduced prices in the German domestic market to attract orders because they were pessimistic about the stock on hand. As a ripple effect in Germany, the CFR Hamburg prices of Amoxicillin Trihydrate settled at USD 40555/MT in December 2022.
For the Quarter Ending September 2022
North America
With prices assembled at USD 44410/MT in July, the North American market for Amoxicillin Trihydrate started the Q3 of 2022 on a downward note. Entering July, buyers only made purchases for instant use caused by both the subpar offtakes and the weak end-user demand. However, the prices of Amoxicillin Trihydrate increased until September and were settled at USD 46450/MT. The US mainly imports Amoxicillin Trihydrate API from China, whereas most factories in China were under maintenance in the final week of July, resulting in lower imports into the US. As August approached, the demand for Amoxicillin Trihydrate in the United States increased and remained persistent by the end of the third quarter due to low inventories among domestic merchants.
Asia- Pacific
In the third quarter of 2022, the price trend for Amoxicillin Trihydrate in the Asia Pacific market exhibited a fluctuating trajectory. The market opened in July with adverse sentiments but enhanced in August, with prices settling at USD 41150/MT in China. The market supply side faced great uncertainty in the first half of the quarter, mainly due to the manufacturing unit's high-temperature maintenance, resulting in supply reduction. These factors caused an escalation in the prices of Amoxicillin Trihydrate in August. However, later the upward trend declined in September, with prices assembling at USD 40225/MT. As the temperature dropped in September, the plants resumed their production, with the market supply returning to normal, and demand became regular from the downstream pharmaceutical sector.
Europe
During Q3 of 2022, the prices of Amoxicillin Trihydrate resembled the trend of the Asia-Pacific region. The price of Amoxicillin Trihydrate first decreased by 2.9 % in July but later increased drastically by 7.5% in August, with values settling at USD 50140/MT. The price rose for Amoxicillin Trihydrate was supported by a combination of factors, including a high demand from end users pharmaceutical, strong purchasing activity, and insufficient supply of the product in the German domestic market. Also, the situation in Europe worsened with ongoing lockdowns in Chinese ports and unrest in Russia and Ukraine. Therefore, by the termination of Q3, the dynamics of the Amoxicillin Trihydrate market were suppressed across the European region, with prices evaluated at USD 48770/MT.
For the Quarter Ending June 2022
North America
The market sentiments of Amoxicillin Trihydrate showcased fluctuating pricing trends in North America during the quarter second of 2022. The prices of Amoxicillin Trihydrate consistently soared till May and then dropped slightly in June, backed by inconsistent downstream demand. The downstream inquiry for Amoxicillin Trihydrate from pharmaceutical industries to treat several bacterial infections such as pneumonia, tonsilitis, sinuses, etc., was strong till May, which later started depleting. Furthermore, the value for upstream was escalating till May, raising the manufacturing cost of Amoxicillin Trihydrate, causing the price hike for Amoxicillin Trihydrate. Later, as the upstream cost reduced along with the deduction in downstream demand, the market value of Amoxicillin Trihydrate dropped considerably. Towards the end of Q2 of 2022, Amoxicillin Trihydrate was assessed at USD 45890/MT for CFR Houston.
Asia- Pacific
Mimicking the north American pricing trend, the price value of Amoxicillin Trihydrate fluctuated in the Asia-Pacific region during the second quarter of 2022, according to market perceptions. The market value of Amoxicillin Trihydrate significantly decreased in April before abruptly rising as the upstream cost decreased and the downstream demand decreased. Later, Amoxicillin Trihydrate prices rose until June, supported by erratic downstream demand. Pharmaceutical firms had a significant need for Amoxicillin Trihydrate to treat various bacterial diseases, including tonsillitis, pneumonia, sinus infections, etc. Additionally, the upstream price was rising, which increased the cost of producing Amoxicillin Trihydrate and thus led to an increase in the API's price. Therefore, Amoxicillin Trihydrate was assessed at INR 2142860/MT for Ex-Vapi towards the end of Q2 of 2022.
Europe
Unlike North America and Asia-pacific, the market value of Amoxicillin Trihydrate soared consistently till June in the European countries during the second quarter of 2022. However, the Amoxicillin Trihydrate price hike in April was much larger than in May and June. Upsurged downstream demand from pharma industries to cure diseases like pneumonia and tonsilitis readily contributed to the price rise of Amoxicillin Trihydrate in the domestic market. Furthermore, the escalated upstream cost on account of augmented raw material prices exacerbated the Amoxicillin Trihydrate's price value even more. Altogether, the downstream offtake and manufacturing costs increased continuously in Europe during the quarter, eventually increasing Amoxicillin Trihydrate prices. Towards the end of Q2 of 2022, Amoxicillin Trihydrate was assessed at USD 48040/MT for CFR Hamburg during June 2022.
